Pharmosa Biopharm Inc. 6875.TWO Stock
Pharmosa Biopharm Inc. Price Chart
Pharmosa Biopharm Inc. 6875.TWO Financial and Trading Overview
| Pharmosa Biopharm Inc. stock price | 74.2 TWD |
| Previous Close | 106 TWD |
| Open | 104.5 TWD |
| Bid | 110.5 TWD x N/A |
| Ask | 112 TWD x N/A |
| Day's Range | 104.5 - 115 TWD |
| 52 Week Range | 31 - 115 TWD |
| Volume | 1.96M TWD |
| Avg. Volume | 461.2K TWD |
| Market Cap | 12.42B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.07 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6875.TWO Valuation Measures
| Enterprise Value | 11B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 16.32415 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -41.295 |
Trading Information
Pharmosa Biopharm Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 205.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 115 TWD |
| 52 Week Low | 31 TWD |
| 50-Day Moving Average | 84.07 TWD |
| 200-Day Moving Average | 65.41 TWD |
6875.TWO Share Statistics
| Avg. Volume (3 month) | 461.2K TWD |
| Avg. Daily Volume (10-Days) | 1.42M TWD |
| Shares Outstanding | 110.93M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -24.49% |
| Return on Equity (ttm) | -41.23% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -266296000 TWD |
| Net Income Avi to Common (ttm) | -266506000 TWD |
| Diluted EPS (ttm) | -2.65 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 672.51M TWD |
| Total Cash Per Share (mrq) | 6.06 TWD |
| Total Debt (mrq) | 21.19M TWD |
| Total Debt/Equity (mrq) | 2.78 TWD |
| Current Ratio (mrq) | 24.651 |
| Book Value Per Share (mrq) | 6.861 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -258307008 TWD |
| Levered Free Cash Flow (ttm) | -165232752 TWD |
Profile of Pharmosa Biopharm Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei City |
| Address | No. 66, Sanchong Road |
| ZIP | 11502 |
| Phone | 886 2 2782 7561 |
| Website | https://www.pharmosa.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 39 |
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, and chronic thromboembolic pulmonary hypertension; L608, an inhalation/device combination for the treatment of pulmonary vascular disease; and L220, an injection/device combination for the treatment of peripheral vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Q&A For Pharmosa Biopharm Inc. Stock
What is a current 6875.TWO stock price?
Pharmosa Biopharm Inc. 6875.TWO stock price today per share is 74.2 TWD.
How to purchase Pharmosa Biopharm Inc. stock?
You can buy 6875.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmosa Biopharm Inc.?
The stock symbol or ticker of Pharmosa Biopharm Inc. is 6875.TWO.
Which industry does the Pharmosa Biopharm Inc. company belong to?
The Pharmosa Biopharm Inc. industry is Biotechnology.
How many shares does Pharmosa Biopharm Inc. have in circulation?
The max supply of Pharmosa Biopharm Inc. shares is 117.2M.
What is Pharmosa Biopharm Inc. Price to Earnings Ratio (PE Ratio)?
Pharmosa Biopharm Inc. PE Ratio is 1060.00000000 now.
What was Pharmosa Biopharm Inc. earnings per share over the trailing 12 months (TTM)?
Pharmosa Biopharm Inc. EPS is 0.07 TWD over the trailing 12 months.
Which sector does the Pharmosa Biopharm Inc. company belong to?
The Pharmosa Biopharm Inc. sector is Healthcare.